Oral Anticoagulation; Improving AF and VTE outcomes (2021 Update)

Summary

Direct oral anticoagulants (DOACs) are increasingly encountered in pharmacy practice, for use in patients with atrial fibrillation (AF), and deep vein thrombosis (DVT). As a result, pharmacists are often asked challenging questions regarding the practical management of patients on DOAC therapy. This lesson provides a practical overview to answering these questions, with a focus on

  1. The role of DOAC therapy in patients with atrial fibrillation (AF) and deep vein thrombosis (DVT)
  2. Optimizing DOAC therapy according to key patient characteristics
  3. The pharmacist’s role in assessing, managing, and monitoring patients on DOAC therapy.